WHO ICTRP trial
Liraglutide in type 1 diabetes. A randomised, double-blind, placebo controlled…
EUCTR2012-001150-26-DK · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2012-001150-26-DK |
|---|---|
| Public title | Liraglutide in type 1 diabetes. A randomised, double-blind, placebo controlled study of the effect of liraglutide as an additional treatment to insulin on HbA1c, body weight and hypoglycaemia in poorly regulated type 1 diabetes patients. |
| Scientific title | Liraglutide in type 1 diabetes. A randomised, double-blind, placebo controlled study of the effect of liraglutide as an additional treatment to insulin on HbA1c, body weight and hypoglycaemia in poorly regulated type 1 diabetes patients. - Lira-1 |
| Primary sponsor | Steno Diabetes Center |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): yes |
| Countries | Denmark |
| Conditions | Primary objective:To investigate the effect of liraglutide 1.8 mg once daily compared to placebo for 24 weeks on change in HbA1c in patients with type 1 diabetes as an add-on therapy to insulin. Secondary objectives:To investigate the… |
| Interventions | Trade Name: Victoza 6 mg/ml injektionsvæske Product Name: Liraglutide Pharmaceutical Form: Suspension for injection in pre-filled pen INN or Proposed INN: LIRAGLUTIDE CAS Number: 204656-20-2 Current Sponsor code: no Other descriptive name… |
| Registration date | May 21, 2012 |
| Secondary IDs | Protokol(Lira-1)v8 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: